Robot pancreas tested for High-Risk diabetes patients
NCT ID NCT07422532
Summary
This study is testing if an automated insulin delivery system can help people with type 2 diabetes who also have advanced kidney failure and are on dialysis. The system uses a continuous glucose monitor and an insulin pump to automatically adjust insulin doses, aiming to keep blood sugar in a safe range. Researchers will compare this automated system to the participants' usual insulin injections to see if it improves blood sugar control, safety, and quality of life over 12 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Guys and St Thomas' Hospitals
London, United Kingdom
Contact Email: •••••@•••••
Contact
-
Hammersmith Hospital
London, United Kingdom
Contact Email: •••••@•••••
-
Manchester Royal Infirmary
Manchester, United Kingdom
Contact Email: •••••@•••••
-
Royal Derby Hospital
Derby, United Kingdom
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.